Showing results (2301-2310 of 2,795) with videos related to

Sort By:
Pageof 280
Advanced Materials (Deerfield Beach, Fla.)|October 5, 2018
Single-Source Bismuth (Transition Metal) Polyoxovanadate Precursors for the Scalable Synthesis of Doped BiVO4 PhotoanodesHaijiao Lu, Virgil Andrei, Kellie J Jenkinson, et al.
Nature Communications|June 27, 2020
A flexible and physically transient electrochemical sensor for real-time wireless nitric oxide monitoringRongfeng Li, Hui Qi, Yuan Ma, et al.
BMC Geriatrics|March 2, 2019
Developing an Intervention for Fall-Related Injuries in Dementia (DIFRID): an integrated, mixed-methods approachAlison Wheatley, Claire Bamford, Caroline Shaw, et al.
Critical Pathways in Cardiology|November 15, 2012
Ability of triage decision rules for rapid electrocardiogram to identify patients with suspected ST-elevation myocardial infarctionAnwar Dayan Osborne, Karim Ali, Douglas Lowery-North, et al.
The Cochrane Database of Systematic Reviews|August 17, 2012
Physiotherapy versus placebo or no intervention in Parkinson's diseaseClaire L Tomlinson, Smitaa Patel, Charmaine Meek, et al.
Chemistry of Materials : a Publication of the American Chemical Society|April 29, 2024
Enhancing Drug Delivery Efficacy Through Bilayer Coating of Zirconium-Based Metal-Organic Frameworks: Sustained Release and Improved Chemical Stability and Cellular Uptake for Cancer TherapyXiewen Liu, Joanna Obacz, Giulia Emanuelli, et al.
Circulation. Cardiovascular Imaging|January 18, 2022
Trajectory of Left Ventricular Remodeling in Children With Valvar Aortic Stenosis Following Balloon Aortic ValvuloplastyKoyelle Papneja, Zachary M Blatman, Ian D Kawpeng, et al.
Investigative Radiology|June 1, 1994
New nonionic triiodinated x-ray contrast media containing the N-(2-hydroxyethyl)aminopropane-2,3-diol side chainY Lin, N O Doran, N E Duffee, et al.
The Cochrane Database of Systematic Reviews|July 13, 2012
Physiotherapy versus placebo or no intervention in Parkinson's diseaseClaire L Tomlinson, Smitaa Patel, Charmaine Meek, et al.
Leukemia|September 12, 2012
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparisonA K Burnett, R K Hills, A E Hunter, et al.
Pageof 280